Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
We designed multivariate logistic models to predict the presence of the KCNH2 mutation or moxifloxacin while adjusting for the level of QTc prolongation and the level of heart rate in LQT2 patients.
|
21315844 |
2011 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
This study characterized the properties of a novel KCNH2 mutation discovered in a LQT2 patient resuscitated from a ventricular fibrillation arrest.
|
21483829 |
2011 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The risk for life-threatening cardiac events from birth through age 40 years (comprising aborted cardiac arrest [ACA] or sudden cardiac death [SCD]) was assessed among 1,166 LQT2 male (n = 490) and female (n = 676) patients by the location of the LQTS-causing mutation in the KCNH2 channel (prespecified in the primary analysis as pore-loop vs. non-pore-loop).
|
21440677 |
2011 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Our results suggest that a rare polymorphism KCNE1-D85N underlies the development of an LQT2 phenotype in this young athlete by interacting with KCNH2 to cause a dominant-negative effect to reduce I(Kr).
|
21712262 |
2011 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Of these, zebrafish models have involved targeting two different KCNH2 gene (long QT syndrome 2) orthologues, termed zerg-2 and zerg-3, with differing cardiac phenotypes.
|
20438705 |
2010 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Type 2 congenital long QT syndrome (LQT2) results from KCNH2 or hERG gene mutations. hERG encodes the K(v)11.1 alpha subunit of the rapidly activating delayed rectifier K(+) current in the heart.
|
20931094 |
2010 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Overlapping LQT1 and LQT2 phenotype in a patient with long QT syndrome associated with loss-of-function variations in KCNQ1 and KCNH2.
|
21164565 |
2010 |
Long Qt Syndrome 2
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants.
|
19841300 |
2009 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
KCNH2 gene mutations disrupting rapid component of I(K) (I(Kr)) underlie type 2 congenital long QT syndrome (LQT2).
|
19419905 |
2009 |
Long Qt Syndrome 2
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test.
|
19716085 |
2009 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants.
|
19841300 |
2009 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test.
|
19716085 |
2009 |
Long Qt Syndrome 2
|
0.800 |
SusceptibilityMutation
|
disease |
CLINVAR |
High prevalence of four long QT syndrome founder mutations in the Finnish population.
|
19160088 |
2009 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test.
|
19716085 |
2009 |
Long Qt Syndrome 2
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
High prevalence of four long QT syndrome founder mutations in the Finnish population.
|
19160088 |
2009 |
Long Qt Syndrome 2
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A novel KCNH2 mutation as a modifier for short QT interval.
|
18692916 |
2009 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Latent genetic backgrounds and molecular pathogenesis in drug-induced long-QT syndrome.
|
19843919 |
2009 |
Long Qt Syndrome 2
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Not all hERG pore domain mutations have a severe phenotype: G584S has an inactivation gating defect with mild phenotype compared to G572S, which has a dominant negative trafficking defect and a severe phenotype.
|
19490267 |
2009 |
Long Qt Syndrome 2
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Identification of the gene causing long QT syndrome in an Israeli family.
|
19070294 |
2008 |
Long Qt Syndrome 2
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Molecular genetic analysis of long QT syndrome in Norway indicating a high prevalence of heterozygous mutation carriers.
|
18752142 |
2008 |
Long Qt Syndrome 2
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Mutation site dependent variability of cardiac events in Japanese LQT2 form of congenital long-QT syndrome.
|
18441445 |
2008 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The present study was designed to determine whether the location of KCNH2 mutations would influence the arrhythmic risk in LQT2 patients.
|
18441445 |
2008 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Type 2 congenital long QT syndrome (LQT-2) is linked to mutations in the human ether a-go-go-related gene (HERG) and is characterized by rate-corrected QT interval (QTc) prolongation, ventricular arrhythmias, syncope, and sudden death.
|
18551196 |
2008 |
Long Qt Syndrome 2
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Long QT and Brugada syndrome gene mutations in New Zealand.
|
17905336 |
2007 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Mechanisms of pharmacological rescue of trafficking-defective hERG mutant channels in human long QT syndrome.
|
16361248 |
2006 |